$2.43
-0.12-4.71%
Last update: Nov 5, 7:46 PM
Pacific Biosciences of California Inc
PACBNASDAQ
The average analyst price target for Pacific Biosciences is $2.41, 2.4% below the current price. Of 12 analysts, 6 rate it Buy, 5 Hold and 1 Sell. Targets range from $1.35 to $4. The latest change came on Nov 5, 2026, when Barclays raised its price target on Pacific Biosciences from $1.25 to $2 and kept an Underweight rating.
Price Target Range — 13 Quarters
Analyst Consensus — 12 Analysts
Rating Trend — Last 9 Months
